Clinical Trial Update: Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon [NA]

View source ↗

Summary

A completed follow-up study in France assesses improvements in walking and pain relief after endovascular treatment of de novo femoropopliteal artery lesions ab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoropopliteal Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• LUTONIX 035 (paclitaxel-coated balloon catheter)
• RANGER Active Balloon (balloon catheter)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Drug-coated Balloon Catheter | NA | Status: COMPLETED